Interleukin 15 Mediates Joint Destruction in Staphylococcus Aureus Arthritis

Inhibition of T cell-dependent and RANKL-dependent osteoclastogenic processes associated with high levels of bone mass in interleukin-15 receptor-deficient mice

(2010) Souad Djaafar et al.   ARTHRITIS AND RHEUMATISM

Tocilizumab for the treatment of rheumatoid arthritis

(2010) Toshio Tanaka et al.   Expert Review of Clinical Immunology

Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype

(2010) Noriyoshi Kurihara et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis

(2010) K. Soderstrom et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases

(2009) Cem Gabay et al.   ARTHRITIS RESEARCH & THERAPY

Bcl-xL is associated with the anti-apoptotic effect of IL-15 on the survival of CD56dim natural killer cells

(2008) Xiaodong Zheng et al.   MOLECULAR IMMUNOLOGY

IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-  and IL-17

(2008) M. Hashizume et al.   RHEUMATOLOGY